Filing Details
- Accession Number:
- 0001209191-20-051291
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-21 16:38:20
- Reporting Period:
- 2020-09-18
- Accepted Time:
- 2020-09-21 16:38:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1757898 | Steris Plc | STE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1651806 | A Daniel Carestio | C/O 70 Sir John Rogerson'S Quay Dublin L2 2 | Sr Vp And Chief Operating Off | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2020-09-18 | 15,000 | $69.72 | 41,314 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2020-09-18 | 14,794 | $175.51 | 26,520 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2020-09-18 | 206 | $176.03 | 26,314 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Employee Stock Option (right to buy) | Acquisiton | 2020-09-18 | 15,000 | $0.00 | 15,000 | $69.72 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-06-01 | No | 4 | M | Direct |
Footnotes
- 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024.
- This exercise of stock options and sale of a total of 14,872 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020.
- Price reflects a weighted average sale price for multiple transactions ranging from $175.02 to $176.00 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This exercise of stock options and sale of a total of 128 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020.
- Price reflects a weighted average sale price for multiple transactions ranging from $176.02 to $176.03 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This option to purchase 15,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS"), in exchange for an option to purchase 15,000 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.
Billionaire Hedge Funds
